U.S. market Closed. Opens in 1 hour 53 minutes

SQLLW | SeqLL Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.0026 - 0.0026
52 Week Range 0.0026 - 0.0026
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 135
Average Volume N/A
Shares Outstanding 46,427,492
Market Cap 120,711
Sector Healthcare
Industry Medical - Diagnostics & Research
IPO Date N/A
Valuation
Profitability
Growth
Health
P/E Ratio -0.01
Forward P/E Ratio N/A
EPS -0.41
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 7
Country USA
Website SQLLW
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease. Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.
SQLLW's peers: GIPRW, BTBDW
*Chart delayed
Analyzing fundamentals for SQLLW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see SQLLW Fundamentals page.

Watching at SQLLW technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on SQLLW Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙